• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血中性粒细胞与淋巴细胞比值可预测米兰标准内肝细胞癌患者肝切除术后的肿瘤复发情况。

Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy.

作者信息

Hu Xu Guang, Mao Wei, Park Yong Keun, Xu Wei Guang, Kim Bong Wan, Wang Hee Jung

机构信息

Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Ajou University School of Medicine, Suwon, Korea.

Department of Surgery, International St. Mary's Hospital, Incheon, Korea.

出版信息

Yonsei Med J. 2016 Sep;57(5):1115-23. doi: 10.3349/ymj.2016.57.5.1115.

DOI:10.3349/ymj.2016.57.5.1115
PMID:27401641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4960376/
Abstract

PURPOSE

The systemic inflammation biomarker, Neutrophil-to-Lymphocyte Ratio (NLR), has been reported as one of the adverse prognostic factors for hepatocellular carcinoma (HCC) patient. The purpose of this study was to evaluate whether NLR could predict the risk of recurrence and death for the HCC patient, according to Milan criteria after hepatectomy.

MATERIALS AND METHODS

Retrospective analysis was performed on a database of HCC patients who underwent hepatectomy between March 2001 and December 2011. The cutoff value of NLR was decided by receiver operating characteristic (ROC) curve analysis. Univariate and multivariate regression analyses were performed to identify predictive factors of recurrence and death.

RESULTS

A total of 213 patients were included in the present study. The median follow-up period was 48 months. One hundred and seven patients were experienced tumor recurrence; forty of them recurred within 12 months (early recurrence). NLR ≥1.505, albumin ≤3.75 g/dL, microvascular invasion and high grade of cirrhosis were found to be independent factors for adverse recurrence-free survival in multivariate regression analysis. And NLR ≥1.945 was also found as a prognosis factor for early recurrence by univariate regression analysis.

CONCLUSION

Elevated preoperative NLR can be easily obtained and reliable biomarker for assessing the tumor recurrence and early recurrence of Milan criteria HCC after the initial hepatectomy.

摘要

目的

全身炎症生物标志物中性粒细胞与淋巴细胞比值(NLR)已被报道为肝细胞癌(HCC)患者不良预后因素之一。本研究旨在评估根据米兰标准行肝切除术后,NLR能否预测HCC患者的复发风险和死亡风险。

材料与方法

对2001年3月至2011年12月期间接受肝切除术的HCC患者数据库进行回顾性分析。通过受试者工作特征(ROC)曲线分析确定NLR的临界值。进行单因素和多因素回归分析以确定复发和死亡的预测因素。

结果

本研究共纳入213例患者。中位随访期为48个月。107例患者出现肿瘤复发;其中40例在12个月内复发(早期复发)。多因素回归分析发现,NLR≥1.505、白蛋白≤3.75g/dL、微血管侵犯和高等级肝硬化是无复发生存不良的独立因素。单因素回归分析还发现NLR≥1.945是早期复发的预后因素。

结论

术前NLR升高是评估米兰标准HCC初次肝切除术后肿瘤复发和早期复发的易于获得且可靠的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/d955b210d637/ymj-57-1115-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/296238bebf9b/ymj-57-1115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/442fd22485b6/ymj-57-1115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/8b54be82b7b7/ymj-57-1115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/d955b210d637/ymj-57-1115-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/296238bebf9b/ymj-57-1115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/442fd22485b6/ymj-57-1115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/8b54be82b7b7/ymj-57-1115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5990/4960376/d955b210d637/ymj-57-1115-g004.jpg

相似文献

1
Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy.血中性粒细胞与淋巴细胞比值可预测米兰标准内肝细胞癌患者肝切除术后的肿瘤复发情况。
Yonsei Med J. 2016 Sep;57(5):1115-23. doi: 10.3349/ymj.2016.57.5.1115.
2
[Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].[肝癌根治性肝切除术后中性粒细胞与淋巴细胞比值与复发及预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):365-371. doi: 10.3760/cma.j.issn.0253-3766.2018.05.009.
3
Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.术前天冬氨酸转氨酶与中性粒细胞比值指数对肝癌肝切除术后患者的预后意义
Oncotarget. 2016 Nov 1;7(44):72276-72289. doi: 10.18632/oncotarget.10848.
4
Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.术后中性粒细胞与淋巴细胞比值联合血小板与淋巴细胞比值可预测肝细胞癌患者的预后。
J Surg Res. 2015 Sep;198(1):73-9. doi: 10.1016/j.jss.2015.05.003. Epub 2015 May 7.
5
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.术前中性粒细胞与淋巴细胞比值是肝癌肝切除术后生存的预测因素:一项回顾性分析。
Ann Surg. 2013 Aug;258(2):301-5. doi: 10.1097/SLA.0b013e318297ad6b.
6
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.在选择乙型肝炎病毒相关肝细胞癌肝移植候选者方面,将杭州标准与中性粒细胞与淋巴细胞比值相结合优于其他标准。
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):588-95. doi: 10.1016/s1499-3872(15)60416-7.
7
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
8
Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection.中性粒细胞与淋巴细胞比值对肝癌根治性切除术后生存的影响。
J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):559-569. doi: 10.1002/jhbp.498. Epub 2017 Oct 3.
9
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及预后营养指数作为巨大(≥10 cm)肝细胞癌肝切除术后早期死亡术前预测指标的意义
J Surg Oncol. 2016 May;113(6):621-7. doi: 10.1002/jso.24197. Epub 2016 Feb 10.
10
Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.中性粒细胞与淋巴细胞比值变化可预测小肝细胞癌的生存率。
J Surg Res. 2014 Dec;192(2):402-8. doi: 10.1016/j.jss.2014.05.078. Epub 2014 Jun 2.

引用本文的文献

1
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis.接受根治性治疗的肝细胞癌患者中性粒细胞与淋巴细胞比值的预后价值:一项系统评价和荟萃分析
BMC Cancer. 2025 Mar 29;25(1):571. doi: 10.1186/s12885-025-13972-w.
2
Emerging Prognostic Markers in Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Narrative Review.肝细胞癌肝切除患者新出现的预后标志物:一项叙述性综述。
Cancers (Basel). 2024 Jun 10;16(12):2183. doi: 10.3390/cancers16122183.
3
Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

本文引用的文献

1
Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.糖尿病对肝细胞癌患者根治性肝切除术后预后的影响。
PLoS One. 2014 Dec 1;9(12):e113858. doi: 10.1371/journal.pone.0113858. eCollection 2014.
2
Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil.中性粒细胞/淋巴细胞比值作为顺铂动脉灌注联合持续氟尿嘧啶肝动脉灌注化疗预后指标的研究
Hepatol Res. 2015 Jul;45(7):755-63. doi: 10.1111/hepr.12417. Epub 2014 Oct 9.
3
Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.
中性粒细胞与淋巴细胞比值升高与肝细胞癌患者预后不良之间的显著关联:一项系统评价和荟萃分析
Front Immunol. 2023 Sep 21;14:1211399. doi: 10.3389/fimmu.2023.1211399. eCollection 2023.
4
Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio.基于中性粒细胞与淋巴细胞比值的术后辅助经动脉化疗栓塞术的治疗效果
Front Surg. 2023 Jan 6;9:1072451. doi: 10.3389/fsurg.2022.1072451. eCollection 2022.
5
Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.基于临床数据库建立炎症标志物列线图模型预测肝癌患者术后的预后。
BMC Cancer. 2022 Mar 7;22(1):249. doi: 10.1186/s12885-022-09345-2.
6
Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值可预测肝细胞癌患者的预后:一项系统评价和荟萃分析
Transl Cancer Res. 2021 Apr;10(4):1667-1678. doi: 10.21037/tcr-20-3237.
7
Neutrophils as potential therapeutic targets in hepatocellular carcinoma.中性粒细胞作为肝细胞癌潜在的治疗靶点。
Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):257-273. doi: 10.1038/s41575-021-00568-5. Epub 2022 Jan 12.
8
Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer.NLR 联合 CIP2A 在结直肠癌患者血清中的预后价值。
BMC Surg. 2021 Jun 18;21(1):297. doi: 10.1186/s12893-021-01273-5.
9
Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.中性粒细胞与淋巴细胞比值和白蛋白-胆红素分级在肝细胞癌中的应用:一项系统综述。
World J Gastroenterol. 2020 Sep 7;26(33):5022-5049. doi: 10.3748/wjg.v26.i33.5022.
10
Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma.载脂蛋白B升高预示肝细胞癌患者术后预后不良。
Onco Targets Ther. 2019 Mar 12;12:1957-1964. doi: 10.2147/OTT.S192631. eCollection 2019.
术前中性粒细胞与淋巴细胞比值可作为根治性切除术后肝细胞癌的新预后标志物。
Transl Oncol. 2014 Apr;7(2):248-55. doi: 10.1016/j.tranon.2014.02.011. Epub 2014 Mar 4.
4
The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib.血液中性粒细胞与淋巴细胞比值可预测接受索拉非尼治疗的晚期肝细胞癌患者的生存率。
Asian Pac J Cancer Prev. 2013;14(9):5527-31. doi: 10.7314/apjcp.2013.14.9.5527.
5
Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.影响活体肝移植后肝细胞癌复发患者生存的预后因素:特别关注中性粒细胞/淋巴细胞比值。
Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.
6
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.术前中性粒细胞与淋巴细胞比值是肝癌肝切除术后生存的预测因素:一项回顾性分析。
Ann Surg. 2013 Aug;258(2):301-5. doi: 10.1097/SLA.0b013e318297ad6b.
7
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.肝细胞癌中的炎症微环境:肿瘤相关巨噬细胞的关键作用。
Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30.
8
The linkage between inflammation and Type 2 diabetes mellitus.炎症与 2 型糖尿病之间的关联。
Diabetes Res Clin Pract. 2013 Feb;99(2):85-92. doi: 10.1016/j.diabres.2012.09.003. Epub 2012 Dec 14.
9
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.中性粒细胞与淋巴细胞比值通过炎症微环境反映肝移植后肝细胞癌的复发。
J Hepatol. 2013 Jan;58(1):58-64. doi: 10.1016/j.jhep.2012.08.017. Epub 2012 Aug 25.
10
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.糖尿病与接受肝癌根治性治疗的患者死亡率增加有关。
Oncologist. 2012;17(6):856-62. doi: 10.1634/theoncologist.2012-0065. Epub 2012 May 23.